Nilogen Oncosystems, 27 Sep 2017 Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden Large cell…
Héctor Martín Abundis Manzano, 26 Sep 2017 Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden Large cell…